Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Bio-Immunity begins voluntary recall of rabies vaccines
The lots are being voluntarily recalled as a precaution following a notification issued by China’s State Food and Drug Administration (SFDA) of the possibility of a flaw in
The lots are being voluntarily recalled as a precaution following a notification issued by China’s State Food and Drug Administration (SFDA) of the possibility of a flaw in
“In the quarter, and in the past year, we’ve taken decisive action as a BioPharma leader to become leaner and more agile,” said James M. Cornelius, chairman and
Rexin-G was well tolerated and there was no dose-limiting toxicity. At dose level I, three patients achieved stable disease with no tumor progression; and at dose level II,
According to Life Technologies, this device simplifies protein analysis workflows by automating Western blotting; a laboratory technique used in a variety of life science research applications, including studies
Sales growth was driven primarily by higher volume and new products, including oxycodone hydrochloride extended-release tablets, which accounted for about $100 million in first-quarter sales. Unfavorable foreign exchange
Perrey joined the company from Third Wave/Hologic Japan and previously held various positions in the Japanese in-vitro diagnostic industry (especially in infectious diseases segments). He was also involved
Adjusted net income, excluding stock option expense and certain other expenses, increased 3% to $1,124 million in the fourth quarter of 2008 compared to $1,088 million in the
Perez comes to Cubist in 2003 as senior vice president, sales and marketing, and led the launch of Cubicin. “Rob’s commercial and operational experience will be particularly helpful
“Allan has played an instrumental role in the development of our noninvasive prenatal diagnostic division, including serving as the principal investigator in a screening study to clinically assess
Jubilant has said that the software to be launched in the US and Europe initially, allows scientists to capture, store, and analyze Oracle 9i/10g based screening data with